Cargando…

Integration of Inflammation-Immune Factors to Build Prognostic Model Predictive of Prognosis and Minimal Residual Disease for Hepatocellular Carcinoma

BACKGROUND: Tumor recurrence after hepatectomy is high for hepatocellular carcinoma (HCC), and minimal residual disease (MRD) could be the underlying mechanism. A predictive model for recurrence and presence of MRD is needed. METHODS: Common inflammation-immune factors were reviewed and selected to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Xin, Huang, Ao, Guo, De-Zhen, Wang, Yu-Peng, Zhang, Shi-Yu, Yan, Jia-Yan, Wang, Xin-Yu, Cao, Ya, Fan, Jia, Zhou, Jian, Fu, Xiu-Tao, Shi, Ying-Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9213691/ https://www.ncbi.nlm.nih.gov/pubmed/35756674 http://dx.doi.org/10.3389/fonc.2022.893268

Ejemplares similares

Circulating immune index predicting the prognosis of patients with hepatocellular carcinoma treated with lenvatinib and immunotherapy
por: Guo, De-Zhen, et al.
Publicado: (2023)

CircRNA-100338 Is Associated With mTOR Signaling Pathway and Poor Prognosis in Hepatocellular Carcinoma
por: Huang, Xiu-Yan, et al.
Publicado: (2019)

The Prognostic Prediction Value of Systemic Inflammation Score and the Development of a Nomogram for Patients With Surgically Treated Breast Cancer
por: Huang, Zhang-Zan, et al.
Publicado: (2020)

Integrative Analysis Identifies Cell-Type-Specific Genes Within Tumor Microenvironment as Prognostic Indicators in Hepatocellular Carcinoma
por: Huang, Zi-Li, et al.
Publicado: (2022)

Re-Emergence of Minimal Residual Disease Detected by Flow Cytometry Predicts an Adverse Outcome in Pediatric Acute Lymphoblastic Leukemia
por: Wang, Yu, et al.
Publicado: (2021)

Prognostic model for predicting outcome and guiding treatment decision for unresectable hepatocellular carcinoma treated with lenvatinib monotherapy or lenvatinib plus immunotherapy
por: Guo, De-Zhen, et al.
Publicado: (2023)

Development of an Aerobic Glycolysis Index for Predicting the Sorafenib Sensitivity and Prognosis of Hepatocellular Carcinoma
por: Pan, Yu, et al.
Publicado: (2021)

Preemptive Immunotherapy for Minimal Residual Disease in Patients With t(8;21) Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation
por: Fan, Shuang, et al.
Publicado: (2022)

Construction and validation of a prognostic model for hepatocellular carcinoma: Inflammatory ferroptosis and mitochondrial metabolism indicate a poor prognosis
por: Han, Fang, et al.
Publicado: (2023)

An inflammation-related gene landscape predicts prognosis and response to immunotherapy in virus-associated hepatocellular carcinoma
por: Gao, Ying-jie, et al.
Publicado: (2023)

A Pre-Operative Prognostic Score for Patients With Advanced Hepatocellular Carcinoma Who Underwent Resection
por: Xiao, Han, et al.
Publicado: (2021)

Development of an Eight-gene Prognostic Model for Overall Survival Prediction in Patients with Hepatocellular Carcinoma
por: Guo, De-Zhen, et al.
Publicado: (2021)

Analysis of risk factors of hepatocellular carcinoma and establishment of a clinical prognosis model
por: Ge, Xin-Yu, et al.
Publicado: (2023)

Preoperative Prognostic Nutritional Index and Neutrophil-to-Lymphocyte Ratio Predict Survival Outcomes of Patients With Hepatocellular Carcinoma After Curative Resection
por: Qu, Zhen, et al.
Publicado: (2022)

Relative T2-FLAIR signal intensity surrounding residual cavity is associated with survival prognosis in patients with lower-grade gliomas
por: Yuan, Tao, et al.
Publicado: (2022)

Analysis of the potential association between ferroptosis and immune in hepatocellular carcinoma and their relationship with prognosis
por: Wen, Kai, et al.
Publicado: (2023)

The prognostic significance of inflammation-immunity-nutrition score on postoperative survival and recurrence in hepatocellular carcinoma patients
por: Liang, Yuxin, et al.
Publicado: (2022)

Genetic testing and prognosis of sarcomatoid hepatocellular carcinoma patients
por: Jia, Bin, et al.
Publicado: (2023)

LASTR is a novel prognostic biomarker and predicts response to cancer immunotherapy in gastric cancer
por: Liu, Jun-Yan, et al.
Publicado: (2022)

Effect of HBsAg expression in liver tissue on prognosis of hepatocellular carcinoma after minimally invasive interventional therapy
por: Liu, Biyu, et al.
Publicado: (2023)

SP70 is a novel biomarker of hepatocellular carcinoma
por: Wang, Lin, et al.
Publicado: (2023)

Early Alpha-Fetoprotein Response Is Associated With Survival in Patients With HBV-Related Hepatocellular Carcinoma Receiving Lenvatinib
por: Liu, Bo, et al.
Publicado: (2022)

Pan-Immune-Inflammation Value: A New Prognostic Index in Operative Breast Cancer
por: Lin, Fei, et al.
Publicado: (2022)

Meta-Analysis of Hematological Biomarkers as Reliable Indicators of Soft Tissue Sarcoma Prognosis
por: Li, Long-Qing, et al.
Publicado: (2020)

Dynamics of Minimal Residual Disease in Neuroblastoma Patients
por: Uemura, Suguru, et al.
Publicado: (2019)

Multiple Omics Integration Reveals Key Circular RNAs in Hepatocellular Carcinoma
por: Huang, Zi-Li, et al.
Publicado: (2021)

Development of a Prognostic Scoring System for Hepatocellular Carcinoma Patients With Main Portal Vein Tumor Thrombus Undergoing Conventional Transarterial Chemoembolization: An Analysis of 173 Patients
por: Li, Jing-huan, et al.
Publicado: (2021)

Efficacy and safety of lenvatinib for preventing tumor recurrence after liver transplantation in hepatocellular carcinoma beyond the Milan criteria
por: Guo, De-Zhen, et al.
Publicado: (2022)

Minimal Residual Disease Assessment in Multiple Myeloma Patients: Minimal Disease With Maximal Implications
por: Charalampous, Charalampos, et al.
Publicado: (2022)

Elevated MTSS1 expression associated with metastasis and poor prognosis of residual hepatitis B-related hepatocellular carcinoma
por: Huang, Xiu-Yan, et al.
Publicado: (2016)

Bioinformatics analysis and experimental verification of the prognostic and biological significance mediated by fatty acid metabolism related genes for hepatocellular carcinoma
por: Zhu, Xiao-Ren, et al.
Publicado: (2022)

Impact of type 2 diabetes mellitus on the prognosis of patients with hepatocellular carcinoma after laparoscopic liver resection: A multicenter retrospective study
por: Yang, Shi-Ye, et al.
Publicado: (2022)

A novel immune-related gene signature predicts the prognosis of hepatocellular carcinoma
por: He, Shujiao, et al.
Publicado: (2022)

Different Effects of Pre-transplantation Measurable Residual Disease on Outcomes According to Transplant Modality in Patients With Philadelphia Chromosome Positive ALL
por: Li, Si-Qi, et al.
Publicado: (2020)

Comprehensive Analysis of SLC17A9 and Its Prognostic Value in Hepatocellular Carcinoma
por: Kui, Xue-Yan, et al.
Publicado: (2022)

Liquid biopsies and minimal residual disease in myeloid malignancies
por: Allam, Sabine, et al.
Publicado: (2023)

Liquid biopsies and minimal residual disease in lymphoid malignancies
por: Bou Zerdan, Maroun, et al.
Publicado: (2023)

Bioinformatics and Experimental Analysis of the Prognostic and Predictive Value of the CHPF Gene on Breast Cancer
por: Li, Wan-Wan, et al.
Publicado: (2022)

Genetic Alterations and Transcriptional Expression of m(6)A RNA Methylation Regulators Drive a Malignant Phenotype and Have Clinical Prognostic Impact in Hepatocellular Carcinoma
por: Zhu, Gui-Qi, et al.
Publicado: (2020)

Prognostic values of ALDOB expression and (18)F-FDG PET/CT in hepatocellular carcinoma
por: Jia, Wenzhi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_i43qsm8cmubkau99bqaaeahk77